This study involved the extensive use of primary and
secondary sources and involved an in-depth analysis of the various factors
affecting the growth of the global Bioprocess
Validation Market. Both primary and secondary research was used
to identify the segmentation types, trends, key players, key market dynamics,
and key player strategies as well as derive the competitive leadership mapping
and competitive landscape in this market.
Recent
Developments in the Global Industry:
# In August 2018,
Merck KGaA launched the BioReliance Product Characterization Portfolio to
enhance its service portfolio in the bioprocess validation market.
# In March 2017,
Toxikon and SG Lab (Italy) entered into a partnership, to extend its analytical
and extractable & leachable testing service portfolio to determine the drug
integrity in the entire life cycle.
# In January
2019, SGS acquired LeanSis Expertos en Productividad S.L. (Spain). This
acquisition provided SGS operational and manufacturing training and capacity
building services to over 200 clients across Spain.
# In February
2018, Pall Corporation expanded its Hoegaarden office in Belgium with new
R&D center, customer demonstration labs, and manufacturing space. This will
help the company to establish its position in the Belgium market.
Critical
questions answered in this Report:
# Where will all
these developments take the industry in the medium-to-long-term?
# What are the
major trends in bioprocess validation?
# Who are the
major end-users of bioprocess validation?
# Which test
types are used mainly for bioprocess validation?
# Which process
component has a higher adoption rate of bioprocess validation?
Find More
Details | Download PDF Brochure@
Factors
Influencing Global Growth:-
Stringent safety and quality regulations governing product
certification and testing across the biopharmaceutical and pharmaceutical
industries, high demand for the outsourcing of bioprocess validation services,
and regulatory mandates in the healthcare industry to maintain compliance with
Good Manufacturing Practices (GMP) are the major factors driving the growth of
this market.
Restraint:
# Issues Related to
Extractables & Leachables
Opportunities:
# Growth
Opportunities in Asia Pacific and Latin American Countries
# Patent Expiry
Challenge:
# Waste Disposal
# Development of New
Validation Methods for Next Generation Bioproducts
Monetary
Growth Expectations, Globally:
According to the Research Study conducted by MarketsandMarkets™:
The global Bioprocess Validation Market exceeded USD 180 million in 2019 and is
projected to be valued over USD 360 million by 2024, at a CAGR of 14.6% during
the forecast period.
Feel FREE to Connect to Our Research Experts@
Geographical Growth Scenario:
North America is expected to account for the largest share
of the bioprocess validation market in 2019, closely followed by Europe.
Factors such as the presence of well-established biopharmaceutical industry in
the region, high R&D expenditure, presence of leading bioprocess validation
service providers, and stringent regulatory requirements for biopharmaceutical
production are driving the growth of the bioprocess validation market in North
America.
Leading Market
Players:
# Merck KGaA (Germany)
# Sartorius Stedim Biotech
(Sartorius AG) (France)
# Pall Corporation (US)
# SGS S.A. (Switzerland)
# Eurofins Scientific
(Luxembourg)
# Cobetter Filtration
Equipment Co., Ltd. (China) and many more…
These companies are focusing on increasing their
presence in high-growth markets through organic and inorganic growth strategies
such as capacity expansions, service launches, agreements, partnerships,
collaborations & acquisitions.
No comments:
Post a Comment